KCT0001138招募中未知
Survey for the development of terminal cancer patients' quality of death evaluation tool among bereaved families
CC Hospital0 个研究点目标入组 250 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •terminal cancer patients' bereaved family who participate in the 54 hospice and palliative care organization bereavement family union
- •-People who is mentally and physically in good condition
- •-People who agree to participate
排除标准
- •-People who disagree to participate
- •-People who is not mentally and physically in good condition
研究者
相似试验
尚未招募
不适用
An evaluation and an examination of the cancer immunology for resectable non-small cell lung cancerPatients with resectable non-small cell lung cancer who are going to receive pulmonary resectionJPRN-UMIN000031128Tohoku Medical and Pharmaceutical University, Tohoku Medical and Pharmaceutical University Hospital20
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab alone or in combination with other cancer therapies.pan tumorMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004362-34-PLBristol-Myers Squibb International Corporation1,231
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab alone or in combination with other cancer therapies.pan tumorMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004362-34-ATBristol-Myers Squibb International Corporation1,231
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab alone or in combinationwith other cancer therapies.EUCTR2018-004362-34-HUBristol-Myers Squibb International Corporation1,231
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab alone or in combination with other cancer therapies.pan tumorMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004362-34-DEBristol-Myers Squibb International Corporation1,231